Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shingo Iwami

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Nature Communications|August 26, 2024
Modelling the effectiveness of an isolation strategy for managing mpox outbreaks with variable infectiousness profilesYong Dam Jeong, William S Hart, Robin N Thompson, et al.
The Journal of Biological Chemistry|December 15, 2019
The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal networkMasashi Iwamoto, Wakana Saso, Kazane Nishioka, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2019
Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalizationMasashi Iwamoto, Wakana Saso, Ryuichi Sugiyama, et al.
Vaccines|April 23, 2022
Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community SurveyMakoto Yoshida, Yurie Kobashi, Takeshi Kawamura, et al.
Communications Medicine|March 14, 2025
Age- and vaccination status-dependent isolation guidelines based on simulation of SARS-CoV-2 Delta cases in SingaporeKeisuke Ejima, Marco Ajelli, Ananya Singh, et al.
Journal of Medical Virology|February 2, 2026
Comparing Cross-Sectional and Longitudinal Study Designs for Accurate Viral Dynamics Estimation: Insights From the NBA Cohort DataJihyeon Kim, Hyeongki Park, Hoong Kai Chua, et al.
Vaccines|November 25, 2023
Antibody Profiling of Microbial Antigens in the Blood of COVID-19 mRNA Vaccine Recipients Using Microbial Protein MicroarraysHiroaki Saito, Hiroki Yoshimura, Makoto Yoshida, et al.
Plos Medicine|July 6, 2021
Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling studyShoya Iwanami, Keisuke Ejima, Kwang Su Kim, et al.
Trials|April 29, 2021
Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trialNaoki Hosogaya, Taiga Miyazaki, Yuri Fukushige, et al.
Cell Reports Methods|April 27, 2022
A widely distributed HIV-1 provirus elimination assay to evaluate latency-reversing agents <i>in vitro</i>Kouki Matsuda, Saiful Islam, Toru Takada, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Nature Communications|August 26, 2024
Modelling the effectiveness of an isolation strategy for managing mpox outbreaks with variable infectiousness profilesYong Dam Jeong, William S Hart, Robin N Thompson, et al.
The Journal of Biological Chemistry|December 15, 2019
The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal networkMasashi Iwamoto, Wakana Saso, Kazane Nishioka, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 7, 2019
Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalizationMasashi Iwamoto, Wakana Saso, Ryuichi Sugiyama, et al.
Vaccines|April 23, 2022
Factors Associated with COVID-19 Vaccine Booster Hesitancy: A Retrospective Cohort Study, Fukushima Vaccination Community SurveyMakoto Yoshida, Yurie Kobashi, Takeshi Kawamura, et al.
Communications Medicine|March 14, 2025
Age- and vaccination status-dependent isolation guidelines based on simulation of SARS-CoV-2 Delta cases in SingaporeKeisuke Ejima, Marco Ajelli, Ananya Singh, et al.
Journal of Medical Virology|February 2, 2026
Comparing Cross-Sectional and Longitudinal Study Designs for Accurate Viral Dynamics Estimation: Insights From the NBA Cohort DataJihyeon Kim, Hyeongki Park, Hoong Kai Chua, et al.
Vaccines|November 25, 2023
Antibody Profiling of Microbial Antigens in the Blood of COVID-19 mRNA Vaccine Recipients Using Microbial Protein MicroarraysHiroaki Saito, Hiroki Yoshimura, Makoto Yoshida, et al.
Plos Medicine|July 6, 2021
Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling studyShoya Iwanami, Keisuke Ejima, Kwang Su Kim, et al.
Trials|April 29, 2021
Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trialNaoki Hosogaya, Taiga Miyazaki, Yuri Fukushige, et al.
Cell Reports Methods|April 27, 2022
A widely distributed HIV-1 provirus elimination assay to evaluate latency-reversing agents <i>in vitro</i>Kouki Matsuda, Saiful Islam, Toru Takada, et al.
Pageof 14